Confounders of severe asthma: diagnoses to consider when asthma symptoms persist despite optimal therapy.
World Allergy Organ J. 2018; 11: 29Raskin J. Marks T. Miller A.Phenotypes and characterization of COPD: a pulmonary rehabilitation perspective.
J Cardiopulm Rehabil Prev. 2018; 38: 43-48Cosio B.G. Dacal D. Perez de Llano L.Asthma-COPD overlap: identification and optimal treatment.
Ther Adv Respir Dis. 2018; 12 (1753466618805662)Sevimli N. Yapar D. Turktas H.The Prevalence of Asthma-COPD Overlap (ACO) Among Patients with Asthma.
Turk Thorac J. 2019; 20: 97-102Hanania N.A. Chipps B.E. Griffin N.M. et al.Omalizumab effectiveness in asthma-COPD overlap: Post hoc analysis of PROSPERO.
J Allergy Clin Immunol. 2019; 143: 1629-16233 e2Diagnosis of asthma-COPD overlap: the five commandments.
Eur Respir J. 2017; 49: 1700506Asthma-COPD overlap syndrome: pathogenesis, clinical features, and therapeutic targets.
BMJ. 2017; 358: j3772Yanagisawa S. Ichinose M.Definition and diagnosis of asthma-COPD overlap (ACO).
Allergol Int. 2018; 67: 172-178Tu X. Donovan C. Kim R.Y. et al.Asthma-COPD overlap: current understanding and the utility of experimental models.
Eur Respir Rev. 2021; 30: 190185McDonald V.M. Gibson P.G."To define is to limit": perspectives on asthma-COPD overlap syndrome and personalised medicine.
Eur Respir J. 2017; 49: 1700336Miravitlles M. Alvarez-Gutierrez F.J. Calle M. et al.Algorithm for identification of asthma-COPD overlap: consensus between the Spanish COPD and asthma guidelines.
Eur Respir J. 2017; 49: 1700068Koblizek V. Chlumsky J. Zindr V. et al.Chronic Obstructive Pulmonary Disease: official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented care.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013; 157: 189-201The Asthma-COPD Overlap Syndrome.
N Engl J Med. 2015; 373: 1241-1249Bujarski S. Parulekar A.D. Sharafkhaneh A. et al.The asthma COPD overlap syndrome (ACOS).
Curr Allergy Asthma Rep. 2015; 15: 509Barrecheguren M. Esquinas C. Miravitlles M.The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges.
Curr Opin Pulm Med. 2015; 21: 74-79de Marco R. Marcon A. Rossi A. et al.Asthma, COPD and overlap syndrome: a longitudinal study in young European adults.
Eur Respir J. 2015; 46: 671-679Morissette M. Godbout K. Cote A. et al.Asthma COPD overlap: Insights into cellular and molecular mechanisms.
Mol Aspects Med. 2021; 85: 101021Kubysheva N. Boldina M. Eliseeva T. et al.Relationship of Serum Levels of IL-17, IL-18, TNF-alpha, and Lung Function Parameters in Patients with COPD, Asthma-COPD Overlap, and Bronchial Asthma.
Mediators Inflamm. 2020; 2020: 4652898Inflammatory mechanisms in patients with chronic obstructive pulmonary disease.
J Allergy Clin Immunol. 2016; 138: 16-27de Llano L.P. Cosio B.G. Iglesias A. et al.Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.
Int J Chron Obstruct Pulmon Dis. 2018; 13: 591-601Hikichi M. Hashimoto S. Gon Y.Asthma and COPD overlap pathophysiology of ACO.
Allergol Int. 2018; 67: 179-186At last - linking ORMDL3 polymorphisms, decreased sphingolipid synthesis, and asthma susceptibility.
J Clin Invest. 2020; 130: 604-607James B. Milstien S. Spiegel S.ORMDL3 and allergic asthma: From physiology to pathology.
J Allergy Clin Immunol. 2019; 144: 634-640Christenson S.A. Steiling K. van den Berge M. et al.Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 2015; 191: 758-766Singh U. Wangia-Anderson V. Bernstein J.A.Chronic rhinitis is a high-risk comorbidity for 30-day hospital readmission of patients with asthma and chronic obstructive pulmonary disease.
J Allergy Clin Immunol Pract. 2019; 7: 279-285Singh S. Amin A.V. Loke Y.K.Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis.
Arch Intern Med. 2009; 169: 219-229Lee S.Y. Park H.Y. Kim E.K. et al.Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome.
Int J Chron Obstruct Pulmon Dis. 2016; 11: 2797-2803Su V.Y. Yang K.Y. Yang Y.H. et al.Use of ICS/LABA Combinations or LAMA Is Associated with a Lower Risk of Acute Exacerbation in Patients with Coexistent COPD and Asthma.
J Allergy Clin Immunol Pract. 2018; 6: 1927-19235 e3Beta2-adrenoceptors: mechanisms of action of beta2-agonists.
Paediatr Respir Rev. 2001; 2: 57-62Louie S. Zeki A.A. Schivo M. et al.The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations.
Expert Rev Clin Pharmacol. 2013; 6: 197-219Yalcin A.D. Celik B. Yalcin A.N.Omalizumab (anti-IgE) therapy in the asthma-COPD overlap syndrome (ACOS) and its effects on circulating cytokine levels.
Immunopharmacol Immunotoxicol. 2016; 38: 253-256
留言 (0)